HMGCR and hyperlipidemia: Statins, one of the primary drugs used for hyperlipidemia treatment, specifically inhibit 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR), the rate-limiting enzyme in cholesterol synthesis.